Clinical Trials in Seattle

Showing 5941-5960 of 9,312 trials

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

NCT02401048

The purpose of this study is to evaluate the efficacy, safety and tolerability of the combination treatment of ibrutinib and MEDI4736 in subjects with relapsed or refractory lymphomas.

Diffuse Large B-Cell LymphomaFollicular Lymphoma

Pharmacyclics LLC.61 participantsStarted May 2015

Birmingham, Alabama, United States • Duarte, California, United States • Stanford, California, United States +8 more locations

COMPLETEDPhase 4< 1 mile

RNS® System LTT Study

NCT00572195

The RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures that are refractory to two or more antiepileptic medications. Candidates will continue to receive their epilepsy medications while participating in the trial.

Epilepsy

NeuroPace230 participantsStarted Apr 2006

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +30 more locations

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

RNS® System LTT Study

Find Trials by Condition in Seattle

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

National Prevalence and Impact of Noninvasive Prenatal Testing

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

Healthy Weight Poster, Multi-site Study

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

ALternate Site Cardiac ReSYNChronization (ALSYNC) Study

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy